Sun Pharma has offered to pay $14.00 a share in an all-cash deal, putting the Indian drugmaker on track to become one of the top three global players in womenā€™s health.
Sun Pharma has offered to pay $14.00 a share in an all-cash deal, putting the Indian drugmaker on track to become one of the top three global players in womenā€™s health.
